Othram, the leading forensic sequencing laboratory for law enforcement, is pleased to announce the appointment of industry veteran Andrew Singer as Chief Commercial Officer. Mr. Singer will lead efforts to expand Othram’s operations throughout North America, delivering on the company’s mission to enable justice for all victims and their families.

Mr. Singer joins Othram after a successful 14-year tenure at Bode Technology, most recently serving as the Vice President of Operations Sales and Global Marketing where he was responsible for applying DNA testing technology in novel ways to help law enforcement solve crimes. Over more than a decade, he substantially grew market share for the company, while becoming a thought leader in the forensic community.

“I am incredibly excited to join Othram and be a part of their mission to create a safer and more just world. Othram has demonstrated a commitment to providing best-in-class DNA testing capabilities while providing answers for previously ‘unsolvable’ crimes,” said Andrew Singer. “There are thousands of families that have been impacted by crime or the loss of a loved one and so many of them are still waiting for answers.”

Othram is the world’s only laboratory purpose-built to combine genome sequencing with advanced human identification applications. The laboratory, based in The Woodlands, Texas, is also the only facility in the United States or Canada offering end-to-end, in-house processing from forensic evidence to investigative leads. Over the last three years, this technology has helped law enforcement crack hundreds of cases at the local, state, and federal level, many of which had been unsolved for decades.

“Justice is a basic human right and Othram is developing the underlying infrastructure to deliver justice to all victims and their families.” said Othram CEO David Mittelman. “We are thrilled that Mr. Singer is joining us on this important mission.”